Naila Wahid
info@coalitionforwomensbrainhealth.org
The current Alzheimer’s and dementia evidence base has insufficiently examined differences in epidemiology and experience for women compared to men. Women’s brain health is both understudied and underfunded compared to men’s brain health. Moreover, women are disproportionately affected by neurological conditions: almost two-thirds of people with Alzheimer’s are women, only 12% of the 2019 NIH funding went to women-focused research, and more than 3 in 5 Alzheimer’s caregivers are women. Understanding and ameliorating these disparities is imperative to establish an effective and equitable healthcare system.
Participation benefits include:
Diana Slowiejko, PharmD, PhD
Principal Medical Scientific Director, Neurology & Neuro Rare Diseases
Genentech
Sandy Gleysteen
Director of Strategic Partnership & Special Projects
Women’s Alzheimer’s Movement (WAM)
Lindsay Chura, PhD
Senior Policy & Research Advisor
AARP
Sarah Lock, JD
Senior VP Policy & Brain Health / Executive Director, Global Council on Brain Health
AARP
Naila Wahid, MS
Principal
Avalere Health
Shayna Adams, MPH
Consultant
Avalere Health
Alexandra Bryan, MPH
Senior Associate
Avalere Health
Holden Corcoran
Senior Associate
Avalere Health
Founding Members:
Genentech
AARP
Women’s Alzheimer’s Movement (WAM)
Contact:
Naila Wahid
info@coalitionforwomensbrainhealth.org